The nation of Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' request for sensitive information.
This move became public after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesman has since clarified that the US was requesting health data for research and profit while was not willing to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more dialogue to reach a deal acceptable to all parties so the country's vital HIV programme can proceed.
Broader Context
This development follows a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement after concerns were filed about the security of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.
Based on reports, 16 nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to share its biological resources and data indefinitely, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our people if a new disease outbreak emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures already established through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to deal with potential pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration could be designed in a manner that respects the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that talks must proceed since a large portion of the country's Aids initiatives were funded by external financing.
"If specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it said.
The halted deal highlights the continuing debate between accepting vital international aid and protecting a country's data in an ever more data-driven world.